Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities

v3.24.3
Accrued Expenses and Other Current Liabilities
 9 Months Ended
Sep. 30, 2024
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): 
  As of
  September 30, 2024 December 31, 2023
Research and development $ 775  $ 352 
Compensation and benefits 2,192  580 
General and administrative 386  830 
Private placement investment transaction costs 1,734  — 
Commercial operations 1,155  1,873 
Royalty payment 241  — 
Lease liability, current 550  537 
Total accrued expenses and other current liabilities $ 7,033  $ 4,172